Relmada Therapeutics, Inc. (RLMD) SEC Filings — 2024
16 SEC filings for Relmada Therapeutics, Inc. (RLMD) in 2024.
Filings
- Relmada Therapeutics Files 8-K Report — 8-K · Dec 9, 2024
- Relmada Therapeutics Files 8-K — 8-K · Dec 4, 2024
- Relmada Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Relmada Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 7, 2024
- Relmada Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 7, 2024
- Relmada Therapeutics Files 8-K on Shareholder Votes and Financials — 8-K · May 30, 2024
- Relmada Therapeutics, Inc. Files Quarterly Report for Period Ended March 31, 2024 — 10-Q · May 8, 2024
- Relmada Therapeutics Revises and Relaunches Pivotal Phase 3 Program for REL-1017 — DEF 14A · Apr 9, 2024
- Relmada Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 19, 2024
- Relmada Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Mar 6, 2024
- Relmada Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Relmada Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Relmada Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- RELMADA 8-K Signals Executive Changes, Compensation Updates — 8-K · Jan 11, 2024
- RELMADA THERAPEUTICS Confirms NASDAQ Listing on Jan 4, 2024 — 8-K · Jan 4, 2024
- RELMADA THERAPEUTICS Reports Officer/Director Changes — 8-K · Jan 3, 2024